dr. Rani Soenen
- ORCID iD
-
0000-0002-7625-6630
Show
Sort by
-
From reactive to predictive : advancing biologic dosing in dermatology
-
- Journal Article
- A1
- open access
Exposure-response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis
-
- Journal Article
- A1
- open access
Demographics, disease characteristics, and time to effective treatment of patients with psoriasis in the Ghent PsoPlus cohort of 2021
-
- Journal Article
- A2
- open access
Ixekizumab trough concentrations in psoriasis : paving the way towards personalised therapy : a cohort study
-
- Journal Article
- A1
- open access
Blocking interleukin-17 in psoriasis : real-world experience from the PsoPlus cohort
-
Therapeutic drug monitoring in psoriasis : from empiric dose adaptations to guided clinical decision making
(2023) -
- Journal Article
- A1
- open access
Promising tools to facilitate the implementation of TDM of biologics in clinical practice
-
- Journal Article
- A1
- open access
Therapeutic drug monitoring in dermatology : the way towards dose optimization of secukinumab in chronic plaque psoriasis
-
Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis : results of a structured survey
-
- Journal Article
- A2
- open access
Effectiveness and tolerability of guselkumab in patients with psoriasis : a longitudinal Belgian retrospective multicenter study